Teams will vie for startup funding and in-kind services in the final round of the 26th annual Henry A. Panasci Jr. Technology Entrepreneurship Competition.
The FDA has approved a drug for patients who are 12 and older with classical Hodgkin lymphoma based on the results of a randomized clinical trial led by a UB researcher.